NPI age
2 years
Enumerated 2024-01-18
● Active Type 2 · Organization
A.arise Llc
A.arise Llc is 1 of 1496 community based residential treatment facility, intellectual and/or developmental disabilities organizations in Texas.
Primary specialty
Community Based Residential Treatment Facility, Intellectual and/or Developmental Disabilities
Practice locations
1
0 secondary on file
Status
Active
No deactivations on record
Authorized official
Odemene
Program Manager
Last NPPES update
2024-01-18
Source: monthly bulk 2026-05
How this organization compares
Across 1496 active community based residential treatment facility, intellectual and/or developmental disabilities providers in Texas.
NPI age
2 years
↓ 6 yr below median
Practice locations
1
0 secondary on file
Subspecialties
0
NPI lifetime · 2024 → 2026
2024-01Enumerated in NPPES
2024
2026
Where they practice
Primary practice location
12261 Fondren Rd Apt 808
Houston, TX 770354008
Mailing address
12261 Fondren Rd Apt 808
Houston, TX 770354008
Authorized official
Lauretta Odemene
Program Manager
📞 3464129057
Specialties
-
Community Based Residential Treatment Facility, Intellectual and/or Developmental Disabilities PrimaryA home-like residential facility providing habilitation, support and monitoring services to individuals diagnosed with intellectual and/or developmental disabilities.
Practice context
Single-site organization. Only one practice location on file.
Provyx · Custom healthcare lists
Need all 1496 Community Based Residential Treatment Facility, Intellectual and/or Developmental Disabilities providers in Texas?
Get the full list as a CSV with verified work emails, direct phones, and LinkedIn URLs.
Request a quote →How to verify this organization
- Confirm the NPI on NPPES.The CMS registry is the system of record. Open NPPES →
- Verify the organization is in good standing.Cross-check with the state's business registration and any applicable licensing boards.
- Confirm payer enrollment if billing.NPI presence does not guarantee active enrollment with Medicare, Medicaid, or commercial payers.